Wellgistics Health, Inc. 8-K

What Happened Wellgistics Health, Inc. (filed 8-K on April 9, 2026) notified Silverback Capital Inc. that it is terminating the Settlement Agreement and Stipulation dated January 28, 2026. The settlement had contemplated issuing shares of Wellgistics common stock in reliance on Section 3(a)(10) of the Securities Act. Prior to termination, the Company issued 6,866,000 shares under that Settlement Agreement. Following termination, the agreement is no longer in effect and no additional shares will be issued under it.

Key Details

• Settlement Agreement dated January 28, 2026 was terminated by written notice (8-K filed April 9, 2026).
• 6,866,000 shares of Wellgistics common stock were issued pursuant to the Settlement Agreement before termination.
• No further issuances will be made under the Settlement Agreement or relying on Section 3(a)(10).
• Silverback Capital was asked to return rights, title and interest in any unpaid claims to the applicable creditors; the Company and Silverback state they have no further obligations under the agreement.
• The Company said it terminated the settlement structure to pursue alternative strategic and financing initiatives; the filing notes this eliminates potential future dilution tied to the settlement.

Why It Matters For investors, the termination removes a planned source of future share issuance tied to the January 28 settlement, reducing a specific potential dilution pathway. However, the 6,866,000 shares already issued remain outstanding and affect current share count. The company intends to seek other strategic and financing options, so investors should watch for subsequent filings disclosing any new financing, equity issuances or material changes to capital structure.